118 related articles for article (PubMed ID: 6239414)
1. Pretreatment of renal allograft recipients with immunosuppression and donor-specific blood.
Anderson CB; Tyler JD; Sicard GA; Anderman CK; Rodey GE; Etheredge EE
Transplantation; 1984 Dec; 38(6):664-8. PubMed ID: 6239414
[TBL] [Abstract][Full Text] [Related]
2. Preoperative immunomodulation of renal allograft recipients by concomitant immunosuppression and donor-specific transfusions.
Anderson CB; Tyler JD; Rodey GE; Etheredge EE; Anderman CK; Flye MW; Jendrisak MD; Sicard GA
Transplant Proc; 1987 Feb; 19(1 Pt 2):1494-7. PubMed ID: 3547868
[TBL] [Abstract][Full Text] [Related]
3. Concomitant immunosuppression and donor-specific transfusions prior to renal transplantation.
Anderson CB; Jendrisak MD; Flye MW; Hanto DW; Anderman CK; Rodey GE; Sicard GA
Transplant Proc; 1989 Feb; 21(1 Pt 2):1828-31. PubMed ID: 2652594
[TBL] [Abstract][Full Text] [Related]
4. Renal allograft recipient immunomodulation by concomitant immunosuppression and donor-specific transfusions.
Anderson CB; Jendrisak MD; Flye MW; Hanto DW; Anderman CK; Rodey GE; Sicard GA
Transplant Proc; 1988 Dec; 20(6):1074-8. PubMed ID: 3059589
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of donor-specific transfusions on long-term renal allograft function.
Anderson CB; Brennan D; Keller C; Goss J; Shenoy S; Burton K; Sicard G; Flye MW
Transplant Proc; 1995 Feb; 27(1):991-4. PubMed ID: 7879258
[TBL] [Abstract][Full Text] [Related]
6. Pretreatment of renal allograft recipients with azathioprine and donor-specific blood products.
Anderson CB; Sicard GA; Etheredge EE
Surgery; 1982 Aug; 92(2):315-21. PubMed ID: 7048600
[TBL] [Abstract][Full Text] [Related]
7. Minimal sensitization and excellent renal allograft outcome following donor-specific blood transfusion with a short course of cyclosporine.
Cheigh JS; Suthanthiran M; Fotino M; Riggio RR; Schechter N; Stubenbord WT; Stenzel KH; Rubin AL
Transplantation; 1991 Feb; 51(2):378-81. PubMed ID: 1825244
[TBL] [Abstract][Full Text] [Related]
8. Successful transplantation of cyclosporine-treated haploidentical living-related renal recipients without blood transfusions.
Flechner SM; Kerman RH; Van Buren C; Kahan BD
Transplantation; 1984 Jan; 37(1):73-6. PubMed ID: 6229913
[TBL] [Abstract][Full Text] [Related]
9. Effect of pretransplant stored donor-specific blood transfusions on early renal allograft survival in one-haplotype living related transplants.
Whelchel JD; Shaw JF; Curtis JJ; Luke RG; Diethelm AG
Transplantation; 1982 Dec; 34(6):326-9. PubMed ID: 6760491
[TBL] [Abstract][Full Text] [Related]
10. Conventional immunosuppression after deliberate third party transfusions versus cyclosporine in living related renal transplant recipients.
Hodge EE; Banowsky LH; Novick AC; Lewis RM; Streem SB; Steinmuller DR; Holzmann JJ; McFarlin L; Graneto DE
J Urol; 1989 Mar; 141(3):495-8. PubMed ID: 2645417
[TBL] [Abstract][Full Text] [Related]
11. Donor-specific transfusions have long-term beneficial effects for human renal allografts.
Flye MW; Burton K; Mohanakumar T; Brennan D; Keller C; Goss JA; Sicard GA; Anderson CB
Transplantation; 1995 Dec; 60(12):1395-401. PubMed ID: 8545863
[TBL] [Abstract][Full Text] [Related]
12. A comparison of 2 protocols for living-related renal transplantation in children: donor-specific transfusions versus cyclosporine.
Leone MR; Alexander SR; Melvin T; Striegel J; Reller K; Norman DJ; Barry JM
J Urol; 1990 Sep; 144(3):721-3. PubMed ID: 2388336
[TBL] [Abstract][Full Text] [Related]
13. Cadaveric renal transplantation with quadruple immunosuppression in patients with a positive antiglobulin crossmatch.
Stratta RJ; Mason B; Lorentzen DF; Sollinger HW; D'Alessandro AM; Pirsch JD; Kalayoglu M; Belzer FO
Transplantation; 1989 Feb; 47(2):282-6. PubMed ID: 2645713
[TBL] [Abstract][Full Text] [Related]
14. The effect of pretransplant stored donor-specific blood transfusion on renal allograft survival in one-haplotype living-related transplant recipients.
Whelchel JD; Curtis JJ; Barger BO; Luke RG; Diethelm AG
Transplantation; 1984 Dec; 38(6):654-6. PubMed ID: 6390829
[TBL] [Abstract][Full Text] [Related]
15. Annual trends and triple therapy--1991-2000.
Nishikawa K; Terasaki PI
Clin Transpl; 2001; ():247-69. PubMed ID: 12211788
[TBL] [Abstract][Full Text] [Related]
16. Donor-specific cellular immunity in rejecting and long-term-surviving class I-disparate rat renal allograft recipients.
Ruiz P; Fuller J; Sanfilippo F
Transplantation; 1990 Jan; 49(1):175-83. PubMed ID: 2301009
[TBL] [Abstract][Full Text] [Related]
17. Living-Donor Kidney Transplant With Preformed Donor-Specific Antibodies.
Itabashi Y; Aikawa A; Muramatsu M; Hyoudou Y; Shinoda K; Takahashi Y; Sakurabayashi K; Mizutani T; Oguchi H; Arai T; Kawamura T; Hamasaki Y; Sakai K; Shishido S
Exp Clin Transplant; 2019 Jan; 17(Suppl 1):43-49. PubMed ID: 30777522
[TBL] [Abstract][Full Text] [Related]
18. Evidence that HLA class II disparity is required for the induction of renal allograft enhancement by donor-specific blood transfusions in man.
Lazda VA; Pollak R; Mozes MF; Barber PL; Jonasson O
Transplantation; 1990 Jun; 49(6):1084-7. PubMed ID: 2360251
[TBL] [Abstract][Full Text] [Related]
19. Donor antigen-specific immunosuppression in cadaveric and living-related donor kidney allograft recipients.
Barber WH; Hudson SL; Deierhoi MH; Laskow DA; Gaston RS; Julian BA; Curtis JJ; Diethelm AG
Clin Transpl; 1990; ():289-300. PubMed ID: 2103152
[TBL] [Abstract][Full Text] [Related]
20. Desensitization protocol for highly sensitized renal transplant patients: a single-center experience.
Kute VB; Vanikar AV; Trivedi HL; Shah PR; Goplani KR; Patel HV; Gumber MR; Patel RD; Kanodia KV; Suthar KS; Trivedi VB; Modi PR
Saudi J Kidney Dis Transpl; 2011 Jul; 22(4):662-9. PubMed ID: 21743208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
